Table 4.
Following clinical discovery of efficacy of drug |
MOR/COX-2/VGSC/SPR |
Following preclinical discovery of efficacy of drug |
A2D/AT2R/KOR/5HT1/FAAH1/CB2/CB1/alpha2 |
Preclinical discovery of pain-related mechanisms |
NMDAR/SNRI/Cav2.2/CGRP/NGF/Nav.18/P2X/GABA/NK1/TRPV1/Kv7/Cav3.2/p38/CCR2 |
Human genetics |
Nav1.7 |